Expert Quality/Pharmaceutical Assessor
Medicines and Healthcare products Regulatory Agency (MHRA), UK, United Kingdom
Dr Ka-Wai Wan is a pharmacist by training and graduated from The School of Pharmacy (University of London). She was trained as a hospital pharmacist before completing her PhD in nanomedicine at the Welsh School of Pharmacy (Cardiff, UK). Her research interests lie in the field of nano-based drug delivery systems for targeted therapy and delivery of macromolecules such as nucleotides and proteins, particularly for cancer and antimicrobial applications. Ka-Wai worked as a research academic for over a decade, and she was a Principal Lecturer in Pharmaceutics and Course Leader for the MSc Industrial Pharmaceutics Programme prior to her transition to the MHRA as a pharmaceutical assessor in 2016. What was meant to be a sabbatical has ultimately changed her career. She is now working as an Expert Quality Assessor at the MHRA, leading on the assessment of nano-based medicinal products, and providing scientific and regulatory advice on innovative medicines, particularly on nanomaterials used for both small and macromolecules delivery. This includes nano-based drug delivery systems using polymers, liposomes and various types of lipid nanoparticles (LNPs) for a wide variety of medical applications, including mRNA/LNP products for vaccines and cancer immunotherapies. She is an invited expert for various national and international regulatory and scientific committees, specifically in relation to nanomedicines and mRNA technologies.
Wednesday, October 8, 2025
4:30 PM - 5:30 PM EST